Mechanisms of pulmonary fibrosis: conference summary.
Strieter
R M
RM
University of California, Los Angeles School of Medicine, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Los Angeles, CA 90095-1922, USA. rstrieter@mednet.ucla.edu
D000818:Animals; D002455:Cell Division; D018925:Chemokines / Q000502:physiology; D016207:Cytokines / Q000502:physiology; D018450:Disease Progression; D005109:Extracellular Matrix / Q000473:pathology / Q000502:physiology; D006801:Humans; D007249:Inflammation / Q000473:pathology / Q000503:physiopathology; D007372:Interferons / Q000627:therapeutic use; D008168:Lung / Q000473:pathology* / Q000503:physiopathology*; D020783:Matrix Metalloproteinase 7 / Q000502:physiology; D020782:Matrix Metalloproteinases / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000401:mortality / Q000473:pathology / Q000503:physiopathology* / Q000628:therapy; D016212:Transforming Growth Factor beta / Q000502:physiology; D053773:Transforming Growth Factor beta1
D018925:Chemokines; D016207:Cytokines; C508960:TGFB1 protein, human; D016212:Transforming Growth Factor beta; D053773:Transforming Growth Factor beta1; D007372:Interferons; D020782:Matrix Metalloproteinases; D020783:Matrix Metalloproteinase 7